JPS609697B2 - 製剤 - Google Patents

製剤

Info

Publication number
JPS609697B2
JPS609697B2 JP52140093A JP14009377A JPS609697B2 JP S609697 B2 JPS609697 B2 JP S609697B2 JP 52140093 A JP52140093 A JP 52140093A JP 14009377 A JP14009377 A JP 14009377A JP S609697 B2 JPS609697 B2 JP S609697B2
Authority
JP
Japan
Prior art keywords
resin
coating
drug
particles
coated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52140093A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5369822A (en
Inventor
イエグナスワニ・ラグフナタン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pennwalt Corp
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of JPS5369822A publication Critical patent/JPS5369822A/ja
Publication of JPS609697B2 publication Critical patent/JPS609697B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
JP52140093A 1976-11-26 1977-11-24 製剤 Expired JPS609697B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24
US800105 1977-05-24
US745325 1985-06-14

Publications (2)

Publication Number Publication Date
JPS5369822A JPS5369822A (en) 1978-06-21
JPS609697B2 true JPS609697B2 (ja) 1985-03-12

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52140093A Expired JPS609697B2 (ja) 1976-11-26 1977-11-24 製剤

Country Status (21)

Country Link
JP (1) JPS609697B2 (fr)
AR (1) AR218047A1 (fr)
AT (1) AT359197B (fr)
AU (1) AU511080B2 (fr)
BE (1) BE861141A (fr)
CA (1) CA1086226A (fr)
CH (1) CH639560A5 (fr)
DE (1) DE2752728C2 (fr)
DK (1) DK150534C (fr)
FI (1) FI65910C (fr)
FR (1) FR2373288A1 (fr)
GB (1) GB1544761A (fr)
GR (1) GR61724B (fr)
IE (1) IE45998B1 (fr)
IL (1) IL53462A (fr)
LU (1) LU78584A1 (fr)
NL (1) NL182283C (fr)
NO (1) NO147626C (fr)
NZ (1) NZ185772A (fr)
PT (1) PT67323B (fr)
SE (1) SE426781B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (fr) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Preparations pharmaceutiques a liberation controlee
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0542926B1 (fr) * 1990-08-07 1995-02-15 Pfizer Inc. Emploi de membranes a polymerisation interfaciale dans des dispositifs de liberation
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
WO2019074829A1 (fr) 2017-10-09 2019-04-18 Rhodes Pharmaceuticals L.P. Compositions pharmaceutiques à base de résinate, et leurs procédés de fabrication et d'utilisation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (fr) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
FR2373288B1 (fr) 1980-06-13
NO147626C (no) 1983-05-25
ATA848077A (de) 1980-03-15
GR61724B (en) 1978-12-29
NL182283C (nl) 1988-02-16
IL53462A0 (en) 1978-01-31
CA1086226A (fr) 1980-09-23
DE2752728A1 (de) 1978-06-01
NZ185772A (en) 1978-12-18
AR218047A1 (es) 1980-05-15
DK150534C (da) 1987-10-12
DK523277A (da) 1978-05-27
IE45998L (en) 1978-05-26
JPS5369822A (en) 1978-06-21
SE426781B (sv) 1983-02-14
FI773568A (fi) 1978-05-27
SE7713370L (sv) 1978-05-27
DE2752728C2 (de) 1985-08-01
PT67323B (en) 1979-04-24
AU3098677A (en) 1979-05-31
IL53462A (en) 1980-12-31
AT359197B (de) 1980-10-27
BE861141A (fr) 1978-03-16
GB1544761A (en) 1979-04-25
FI65910C (fi) 1984-08-10
FI65910B (fi) 1984-04-30
NO147626B (no) 1983-02-07
PT67323A (en) 1977-12-01
CH639560A5 (en) 1983-11-30
NL182283B (nl) 1987-09-16
LU78584A1 (fr) 1978-04-20
IE45998B1 (en) 1983-01-26
NL7712996A (nl) 1978-05-30
NO774051L (no) 1978-05-29
AU511080B2 (en) 1980-07-24
FR2373288A1 (fr) 1978-07-07
DK150534B (da) 1987-03-23

Similar Documents

Publication Publication Date Title
US4221778A (en) Prolonged release pharmaceutical preparations
Raghunathan et al. Sustained‐release drug delivery system I: Coated ion‐exchange resin system for phenylpropanolamine and other drugs
US4847077A (en) Controlled release pharmaceutical preparations
EP2645996B1 (fr) Procédés pour la preparation d'une composition comprennant d'inhibiteurs de la pompe à protons
US20230248676A1 (en) Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
KR940000100B1 (ko) 메토프롤롤염을 함유하는 서방형 제제의 제조방법
US5188841A (en) Sustained release pharmaceutical formulations
JPH05279247A (ja) 徐放性液剤
PT642785E (pt) Sistemas de hidrogel heterodisperso de libertacao sustida
CZ160194A3 (en) Solid medicament form with controlled release of active component
KR20080108520A (ko) 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제
DK160601B (da) Farmaceutisk harpiksholdigt, sustained release praeparat med kontrolleret afgivelse af et farmaceutisk acceptabelt syreadditionssalt af dextromethorphan samt fremgangsmaade til fremstilling deraf
SK672003A3 (en) Stable salts of o-acetylsalicylic acid with basic amino acids
PT1954251E (pt) Composição de libertação prolongada da substância ativa, seu método de preparação e sua utilização
WO2015076821A1 (fr) Nouvelle formulation de clonidine
JPS609697B2 (ja) 製剤
JPH0649645B2 (ja) 徐放性医薬製剤
JP2670777B2 (ja) 被覆性イオン交換樹脂
JPH0428685B2 (fr)
EP0386023A1 (fr) Preparation de nifedipine a liberation soutenue
PT99912A (pt) Processo para a preparacao de uma composicao farmaceutica oral compreendendo particulas de resina de permuta cationica que contem uma droga de poliamina farmacologicamente activa ligada a referida resina
JPS6335526A (ja) ポリマ−処理イオン交換樹脂
CN106999433A (zh) 用于制备去氧肾上腺素树脂酸盐颗粒的方法；去氧肾上腺素树脂酸盐颗粒；以及去氧肾上腺素树脂酸盐颗粒在药物制剂中的用途
CA2370355A1 (fr) Formulations multiparticulaires de sels de lithium pour administration orale possiblement quotidienne
PL186915B1 (pl) Tabletka zawierająca kwas tolfenamowy lub jego farmaceutycznie dopuszczalną sól i sposób wytwarzania takiej tabletki